Agnieszka Kubik-Zahorodna

Agnieszka Kubik-Zahorodna

Auto-generated profile, based on publicly available information

Agnieszka Kubik-Zahorodna

Czech Centre for Phenogenomics, Institute of Molecular Genetics, Czech Academy of Sciences, Vestec, Czech Republic

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2021 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
LXLei Xing
Lei Xing
AKAgnieszka Kubik‐Zahorodna
Agnieszka Kubik‐Zahorodna
TNTakashi Namba
Takashi Namba
APAnneline Pinson
Anneline Pinson
MFMarta Florio
Marta Florio
WHWieland B. Huttner
Wieland B. Huttner
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

30 January 2026 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
PDF file
KFKlevinda Fili
Klevinda Fili
VKViktor Kuchtiak
Viktor Kuchtiak
ETEni Tomovic
Eni Tomovic
MSMiriam Candelas Serra
Miriam Candelas Serra
AKAgnieszka Kubik-Zahorodna
Agnieszka Kubik-Zahorodna
LVLadislav Vyklický
Ladislav Vyklický
Pathogenic variants in GRIN2B , encoding the NMDA receptor (NMDAR) GluN2B subunit, are linked to intellectual disability (ID) and related neurodevelopmental disorders. While most disease-associated variants are missense, protein-truncating variants (PTVs) may cause haploinsufficiency with less severe phenotypes. Here, we characterize a knock-in mouse model carrying the GluN2B-L825Ffs*15 PTV ( Grin2b +/Δ ). Proteomic analysis revealed markedly reduced full-length GluN2B protein and no detectable truncated GluN2B, accompanied by a small compensatory increase in GluN2A. Electrophysiology in hippocampal neurons demonstrated reduced NMDA-induced currents, diminished ifenprodil sensitivity, and accelerated NMDAR-mediated EPSC deactivation, consistent with a shift toward GluN2A-containing receptors. AMPAR-mEPSC amplitudes were increased, indicating altered excitatory synaptic function. Behaviorally, Grin2b +/Δ mice exhibited hypoactivity, increased anxiety in males, and impaired sensorimotor gating in both sexes, while learning, memory, and social behaviors remained largely intact. These results demonstrate that a monoallelic GluN2B PTV alters NMDAR subunit composition and function, producing moderate behavioral effects, and provide insight into mechanisms underlying GRIN2B -associated ID.

3 October 2025 in bioRxiv
Verified
Preprint
Open access
KFKlevinda Fili
Klevinda Fili
VKViktor Kuchtiak
Viktor Kuchtiak
ETEni Tomovic
Eni Tomovic
MSMiriam Candelas Serra
Miriam Candelas Serra
AKAgnieszka Kubik-Zahorodna
Agnieszka Kubik-Zahorodna
LVLadislav Vyklický
Ladislav Vyklický
Pathogenic variants in GRIN2B , encoding the NMDA receptor (NMDAR) GluN2B subunit, are linked to intellectual disability (ID) and related neurodevelopmental disorders. While most disease-associated variants are missense, protein-truncating variants (PTVs) may cause haploinsufficiency with less severe phenotypes. Here, we characterize a knock-in mouse model carrying the GluN2B-L825Ffs*15 PTV ( Grin2b +/Δ ). Proteomic analysis revealed markedly reduced full-length GluN2B protein and no detectable truncated GluN2B, accompanied by a compensatory increase in GluN2A. Electrophysiology in hippocampal neurons demonstrated reduced NMDA-induced currents, diminished ifenprodil sensitivity, and accelerated NMDAR-mediated EPSC deactivation, consistent with a shift toward GluN2A-containing receptors. AMPAR-mEPSC amplitudes were increased, indicating altered excitatory synaptic function. Behaviorally, Grin2b +/Δ mice exhibited hypoactivity, increased anxiety in males, and impaired sensorimotor gating in both sexes, while learning, memory, and social behaviors remained largely intact. These results demonstrate that a monoallelic GluN2B PTV alters NMDAR subunit composition and function, producing moderate behavioral effects, and provide insight into mechanisms underlying GRIN2B -associated ID.